Manmeet Soni - 03 Jan 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: COO, CFO and President
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: RETA
Transactions as of: 03 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 16:17:13 UTC
Previous filing: 23 May 2022
Next filing: 01 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$0	+23,513	+34%	$0.000000	92,513	03 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Employee Stock Option (right-to-buy)	Award	$0	+95,475		$0.000000	95,475	03 Jan 2023	Class A common stock	95,475	$36.71	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
F2	The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.